Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
13
×
cancer
13
×
national blog main
life sciences
boston blog main
boston top stories
national top stories
san francisco blog main
texas blog main
texas top stories
new york blog main
san diego blog main
san diego top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
startups
wisconsin blog main
wisconsin top stories
fda
medical devices
novartis
bristol-myers squibb
cancer immunotherapy
deals
drugs
eli lilly
innovation
investing
What
new
13
×
bio
companies
drug
ipo
life
medicines
roundup
cancer
drugs
sciences
announced
based
biotech
brings
cells
develop
developing
diseases
firm
firms
google
google’s
latest
lead
medical
million
plan
professionals
san
science
therapeutics
venture
work
action
activity
addition
advance
advantages
aging
Language
unset
unknown
Current search:
new
×
cancer
×
biotech
×
@techcrunch.com
2 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@techcrunch.com
4 years ago
Google’s SMILY is reverse image search for cancer diagnosis
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston
@xconomy.com
5 years ago
San Antonio Develops “Action Plan” to Draw Life Sciences Businesses
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs
@venturebeat.com
7 years ago
Google’s Calico partners with new biotech firm to develop anti-aging and cancer drugs